Synthetic opioids

In this Thursday, Dec. 19, 2019 photo, pedestrians pass at St. Luke's Cornwall Hospital in Newburgh, N.Y. The hospital adopted the Hudson Valley Interlink Analytic System earlier this year, which tracks drug overdoses in New York. The system is among a number of surveillance systems being adopted around the country by police, government agencies and community groups. (AP Photo/Frank Franklin II)
1010 WINS Newsroom
December 23, 2019 - 2:44 pm
ALBANY, N.Y. (AP) — Drug overdose patients rushed to some emergency rooms in New York's Hudson Valley are asked a series of questions: Do you have stable housing? Do you have food? Times and location of overdoses are noted, too. The information is entered into a new overdose-tracking system that...
Read More
CORRECTS TO CAPITAL, NOT CAPITOL- In this Nov. 14, 2019 photo, Jamie Cline poses for a photo behind a glass window in a door at the Olympia Bupe Clinic at the Capital Recovery Center in Olympia, Wash., which helps people addicted to heroin and other opiates get prescriptions for buprenorphine, a medicine that prevents withdrawal sickness in people trying to stop using opiates. At the clinic, a doctor is working to spread a philosophy called "medication first," which scraps requirements for counseling, abstinence or even a commitment to recovery in the battle against opioid addiction. (AP Photo/Ted S. Warren)
1010 WINS Newsroom
December 18, 2019 - 1:57 pm
Read More
FILE - In this Thursday, Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. A new court filing shows that the wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined in 2007 for misleading marketing of the powerful prescription painkiller. (AP Photo/Frank Franklin II, File)
1010 WINS Newsroom
December 16, 2019 - 9:22 pm
The wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined for misleading marketing of the powerful prescription painkiller. A court filing made by the company Monday evening shows Purdue made payments for the benefit of members of the...
Read More
This Dec. 12, 2019, photo shows a sign at the Mundipharma International headquarters at Cambridge Science Park in England. Mundipharma is the international affiliate of Purdue Pharma, the maker of the blockbuster painkiller OxyContin. Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication. (AP Photo/Leila Coker)
1010 WINS Newsroom
December 15, 2019 - 10:06 pm
The gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on its walls said. Some conference attendees were stunned when they saw the company logo: Mundipharma, the...
Read More
In this Thursday, Oct. 31, 2019, photo, a recovering tramadol user waits for her medication at a de-addiction center in Kapurthala, in the northern Indian state of Punjab. The pills were everywhere, as legitimate medication sold in pharmacies, but also illicit counterfeits hawked by itinerant peddlers and street vendors. India has twice the global average of illicit opiate consumption. Researchers estimate about 4 million Indians use heroin or other opioids, and a quarter of them live in the Punjab, India's agricultural heartland bordering Pakistan. (AP Photo/Channi Anand)
1010 WINS Newsroom
December 13, 2019 - 3:23 pm
KAPURTHALA, India (AP) — Reports rolled in with escalating urgency — pills seized by the truckload, pills swallowed by schoolchildren, pills in the pockets of dead terrorists. These pills, the world has been told, are safer than the OxyContins, the Vicodins, the fentanyls that have wreaked so much...
Read More
House Judiciary Committee Chairman Rep. Jerrold Nadler, D-N.Y., gavels a recess of a House Judiciary Committee markup of the articles of impeachment against President Donald Trump and announces the committee will reconvene on Friday for votes, on Capitol Hill, Thursday, Dec. 12, 2019, in Washington. (AP Photo/Alex Brandon)
1010 WINS Newsroom
December 13, 2019 - 6:19 am
Your daily look at late-breaking news, upcoming events and the stories that will be talked about today: 1. BREXIT CLOSER AFTER TORY MAJORITY IN ELECTION Prime Minister Boris Johnson’s Conservative Party wins a decisive majority of seats in Britain's Parliament — an outcome that should pave the way...
Read More
1010 WINS Newsroom
December 12, 2019 - 2:21 pm
EGG HARBOR TOWNSHIP, N.J. (AP) — The federal government is enlisting the help of the private sector to develop better ways to spot and intercept illicit opioids shipped into the United States through the mail. Several federal agencies on Thursday awarded a $500,000 prize to a Massachusetts firm...
Read More
1010 WINS Newsroom
December 12, 2019 - 1:54 pm
SAN DIEGO (AP) — Major League Baseball will start testing for opioids and cocaine, but only players who do not cooperate with their treatment plans will be subject to discipline. Marijuana will be removed from the list of drugs of abuse and will be treated the same as alcohol as part of changes...
Read More
Worker Gabe Ryan removes a sign that includes the name Arthur M. Sackler at an entrance to Tufts School of Medicine, Thursday, Dec. 5, 2019, in Boston. Tufts University says it is stripping the Sackler name from its campus in recognition of the family's connection to the opioid crisis. (AP Photo/Steven Senne)
1010 WINS Newsroom
December 05, 2019 - 8:09 pm
BOSTON (AP) — Tufts University is cutting ties with the billionaire family that owns OxyContin maker Purdue Pharma, saying it will strip the Sackler name from its campus and accept no further donations amid concerns over the family's role in the opioid crisis. University officials announced the...
Read More
FILE - This June 17, 2019, file photo shows 5-mg pills of Oxycodone. The judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma will consider Wednesday, Dec. 4, 2019 whether the company's CEO should get a bonus equal to half his $2.6 million salary. (AP Photo/Keith Srakocic, File)
1010 WINS Newsroom
December 04, 2019 - 6:55 pm
WHITE PLAINS, N.Y. (AP) — More time is needed to sort out whether the CEO of OxyContin maker Purdue Pharma should receive a $1.3 million bonus next year, but the company should be allowed to pay about $35 million in bonuses to 682 other employees, the judge overseeing the company's bankruptcy case...
Read More

Pages